Novo Giuseppina, Bagger Jens Peder, Carta Riccardo, Koutroulis George, Hall Roger, Nihoyannopoulos Petros
Division of Cardiology, Department of Internal Medicine, Cardiovascular and Nephro-Urological Diseases, University of Palermo, Palermo, Italy.
J Cardiovasc Med (Hagerstown). 2006 May;7(5):335-9. doi: 10.2459/01.JCM.0000223255.24309.fa.
Enhanced external counterpulsation (EECP) is a noninvasive, well-tolerated treatment, effective for managing patients with refractory angina pectoris. The aim of this study was to evaluate the efficacy of EECP to relieve symptoms, to decrease myocardial ischaemia and to improve cardiac performance in patients with intractable angina, refractory to surgical and medical treatment.
Twenty-five patients (24 men and one woman, mean age 65 years) with persistent ischaemia notwithstanding optimal medical therapy or after interventional or surgical procedure, received EECP sessions for 35 h. Each patient underwent dobutamine stress echocardiography before and after treatment. We evaluated modifications in either cardiac systolic or diastolic function, and in wall motion score index.
Eighty-four percent of patients showed an increase in at least one functional angina class. We did not observe any significant changes in fractional shortening and diastolic function. Thirty-six percent of patients had a reduction in the area of inducible ischaemia at dobutamine stress echocardiography after treatment. Unfortunately, because of the small sample size, we did not find any statistically significant difference. There was a trend showing that patients who benefited the most were those with the worst systolic function and with severely compromised segmental kinesis (P = NS).
EECP is effective in relieving symptoms in patients with refractory angina and may reduce inducible ischaemia at dobutamine stress echocardiography, especially in patients with reduced systolic function and compromised segmental kinesis.
增强型体外反搏(EECP)是一种无创且耐受性良好的治疗方法,对难治性心绞痛患者的治疗有效。本研究的目的是评估EECP在缓解症状、减少心肌缺血以及改善经手术和药物治疗无效的顽固性心绞痛患者心脏功能方面的疗效。
25例患者(24例男性,1例女性,平均年龄65岁),尽管接受了最佳药物治疗或在介入或手术后仍存在持续性缺血,接受了35小时的EECP治疗。每位患者在治疗前后均接受多巴酚丁胺负荷超声心动图检查。我们评估了心脏收缩或舒张功能以及壁运动评分指数的变化。
84%的患者至少有一个功能性心绞痛分级得到改善。我们未观察到缩短分数和舒张功能有任何显著变化。36%的患者在治疗后多巴酚丁胺负荷超声心动图检查时可诱导缺血面积减小。遗憾的是,由于样本量小,我们未发现任何统计学上的显著差异。有一个趋势表明,受益最大的患者是那些收缩功能最差且节段性运动严重受损的患者(P=无显著性差异)。
EECP对难治性心绞痛患者的症状缓解有效,并且可能在多巴酚丁胺负荷超声心动图检查时减少可诱导的缺血,尤其是在收缩功能降低和节段性运动受损的患者中。